The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,3,4-trihydroxy-5-oxohexane-1,6-diyl bis(dihydrogen phosphate) ID: ALA1235112
Max Phase: Preclinical
Molecular Formula: C6H14O12P2
Molecular Weight: 340.11
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(COP(=O)(O)O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
Standard InChI: InChI=1S/C6H14O12P2/c7-3(1-17-19(11,12)13)5(9)6(10)4(8)2-18-20(14,15)16/h3,5-7,9-10H,1-2H2,(H2,11,12,13)(H2,14,15,16)/t3-,5-,6-/m1/s1
Standard InChI Key: XPYBSIWDXQFNMH-UYFOZJQFSA-N
Molfile:
RDKit 2D
20 19 0 0 0 0 0 0 0 0999 V2000
-3.2030 -0.2731 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
-3.9175 -0.6856 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7905 -0.9876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6155 0.4413 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4885 0.1394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7741 -0.2731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0596 0.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0596 0.9644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3451 -0.2731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3451 -1.0981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3693 0.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3693 0.9644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0838 -0.2731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0838 -1.0981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7983 0.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5128 -0.2731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2272 0.1394 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
3.9417 0.5519 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8147 0.8538 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6397 -0.5751 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4 1 2 0
2 1 1 0
5 1 1 0
3 1 1 0
6 5 1 0
6 7 1 0
7 9 1 0
7 8 2 0
9 11 1 0
9 10 1 6
11 13 1 0
11 12 1 6
13 14 1 1
13 15 1 0
15 16 1 0
16 17 1 0
18 17 2 0
20 17 1 0
19 17 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.11Molecular Weight (Monoisotopic): 339.9960AlogP: -3.14#Rotatable Bonds: 9Polar Surface Area: 211.28Molecular Species: ACIDHBA: 8HBD: 7#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.01CX Basic pKa: ┄CX LogP: -3.51CX LogD: -10.38Aromatic Rings: ┄Heavy Atoms: 20QED Weighted: 0.21Np Likeness Score: 1.20
References 1. Daher R, Coinçon M, Fonvielle M, Gest PM, Guerin ME, Jackson M, Sygusch J, Therisod M.. (2010) Rational design, synthesis, and evaluation of new selective inhibitors of microbial class II (zinc dependent) fructose bis-phosphate aldolases., 53 (21): [PMID:20929256 ] [10.1021/jm1009814 ] 2. Mabiala-Bassiloua CG, Arthus-Cartier G, Hannaert V, Thérisod H, Sygusch J, Thérisod M.. (2011) Mannitol Bis-phosphate Based Inhibitors of Fructose 1,6-Bisphosphate Aldolases., 2 (11): [PMID:24900268 ] [10.1021/ml200129s ] 3. Xu Y, Liu XH, Saunders M, Pearce S, Foulks JM, Parnell KM, Clifford A, Nix RN, Bullough J, Hendrickson TF, Wright K, McCullar MV, Kanner SB, Ho KK.. (2014) Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2)., 24 (2): [PMID:24374270 ] [10.1016/j.bmcl.2013.12.028 ]